Posted on 3/17/17
Shepley Bulfinch Wins ACHA Legacy Project Award for Bronson Methodist Hospital
Shepley Bulfinch, a national architecture firm known for design excellence and innovation with offices in Boston, Houston
Posted on 3/17/17
Editas Medicine, Inc. Announces Pricing of $90 Million Offering of Common Stock
CAMBRIDGE, Mass., March 16, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the pricing of an underwritten offering of . . .
Posted on 3/16/17
Magellan Diagnostics and PDXWildlife Partner
Magellan Diagnostics, the maker of a point-of-care blood lead analyzer, has announced an agreement to provide its LeadCare® II testing system to PDXWildlife at the Bifengxia . . .
Posted on 3/16/17
Catabasis Pharmaceuticals Reports Q4 and Full Year 2016 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and full year ended December 31, 2016, and . . .
Posted on 3/15/17
Corindus Announces Partnership with WakeMed Health & Hospitals
WALTHAM, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS) today announced that WakeMed Health & Hospitals will partner with Corindus to develop a national center of . . .
Posted on 3/14/17
MedAptus and MD Interconnect Sign Partnership
MedAptus®, a Boston-based healthcare technology company, has signed a partnership agreement with MD Interconnect, a mobile health technology company, to provide the next generation of total . . .
Posted on 3/14/17
ConsumerMedical Enters into Agreement with CoreTrust
ConsumerMedical, a health care decision support and concierge-company, announced that it has signed an agreement with CoreTrust, a group purchasing organization for large corporations and private . . .
Posted on 3/14/17
Vedantra Pharmaceuticals Announces a Joint Research Collaboration with Neon Therapeutics
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedantra Pharmaceuticals, Inc., an immunotherapy company focused on developing products for cancer and infectious disease, today announced a joint collaboration to explore cancer vaccine . . .
Posted on 3/14/17
IDC Health Insights Opens Nominations for the 2017 HealthTech Rankings
FRAMINGHAM, Mass.--(BUSINESS WIRE)--IDC Health Insights today announced that nominations are now open for the 2017 IDC Health Insights HealthTech Rankings, an industry award program that categorizes . . .
Posted on 3/14/17
Advanced Radiology Opens New Imaging Center in Wilton, CT
Advanced Radiology Consultants has announced the opening of its new imaging center at 30 Danbury Road in Wilton, CT. The Wilton office, the company's eighth, joins . . .
Posted on 3/14/17
Stellar Biotechnologies and Matrivax Sign Agreement
Stellar Biotechnologies, Inc. (Nasdaq: SBOT), a leading manufacturer of a key protein utilized in immunotherapy development pipelines, and Matrivax Inc., a vaccine biotechnology company, today announced . . .
Posted on 3/14/17
PAREXEL Named a FlexJobs Top 100 Company to Watch for Telecommuting and Remote Jobs in 2017
BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named to the FlexJobs Top 100 Companies to . . .
Posted on 3/14/17
Lantheus Holdings Announces Public Secondary Offering of 3M Shares of Common Stock
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ:LNTH), today announced an agreement to sell 3,000,000 shares of its common stock to be offered by certain of its . . .
Posted on 3/13/17
Better Buy: Agenus Inc. vs. Celldex Therapeutics
Agenus Inc (NASDAQ:AGEN) and Celldex Therapeutics, Inc. (NASDAQ:CLDX) bear an uncanny resemblance to each other. Both clinical-stage biotechs are focused on developing novel cancer therapies and . . .
Posted on 3/13/17
Why Warren Buffett Thinks Berkshire Hathaway Stock Is Worth At Least $206,500
Warren Buffett's exact method for valuing a stock, including Berkshire Hathaway(NYSE:BRK-A) (NYSE:BRK-B) isn't public information. However, Buffett has given us a concrete price level -- 120% . . .
Posted on 3/13/17
Arcadia Healthcare Solutions Rated in 2016 KLAS Population Health Management Performance Report
BURLINGTON, Mass.--(BUSINESS WIRE)--Arcadia Healthcare Solutions announced today their rating in a recent KLASreport in their core Population Health Management technology market. “Arcadia Healthcare is new to . . .
Posted on 3/10/17
Harvard Bioscience's (HBIO) CEO Jeffrey Duchemin on Q4 2016 Results - Earnings Call Transcript
Harvard Bioscience, Inc. (NASDAQ:HBIO)Q4 2016 Results Earnings Conference CallMarch 9, 2017 4:30 p.m. ETExecutivesCorey Manchester - Director, Finance and Investor RelationsJeffrey Duchemin - President and Chief . . .
Posted on 3/10/17
Biostage, Inc. 2016 Q4 - Results - Earnings Call Slides
The following slide deck was published by Biostage, Inc. in conjunction with their 2016 Q4 earnings call. 114READ FULL ARTICLE HERE
Posted on 3/10/17
Vertex's $160M Deal With Concert Pharmaceuticals
This week began with Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announcing a deal to buy the development and commercialization rights of Concert Pharmaceuticals
Posted on 3/10/17
Fresenius Medical Care and Humana Partner
WALTHAM, Mass.--(BUSINESS WIRE)--Fresenius Medical Care North America (FMCNA), a division of Fresenius Medical Care (NYSE: FMS), announced today that it is joining forces with Humana Inc. . . .
Posted on 3/9/17
Forget the Distractions: Bristol-Myers Squibb Is a Bargain
What will Carl Icahn do? Will Bristol-Myers Squibb (NYSE:BMY) be acquired? How will Opdivo fare against Merck's (NYSE:MRK) Keytruda?There are plenty of unanswered questions swirling around . . .
Posted on 3/8/17
Massachusetts Black Lawyers Association and Boston Police Department Educate Students on Rights
The Massachusetts Black Lawyers Association and the Boston Police Department Area B-3 hosted the 3rd Annual “Know Your Rights Youth Forum” for middle and high school . . .
Posted on 3/8/17
What Illumina's and Bristol-Myers Squibb's Latest GRAIL Moves Mean for Investors
There was a step forward and a step backward last week related to GRAIL, the company seeking to develop a simple DNA blood test to detect . . .
Posted on 3/8/17
The Big Reason Bristol-Myers Squibb Company Stock Exploded 15% Higher in February
What happenedShares of Bristol-Myers Squibb (NYSE:BMY), a U.S. drug giant that's primarily focused on oncology, cardiovascular, and immunoscience therapies, catapulted higher by 15% during February, according . . .
Posted on 3/8/17
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Novartis
Few companies can claim to have helped improve more individuals' eyesight than Regeneron Pharmaceuticals (NASDAQ:REGN) and Novartis (NYSE:NVS). Regeneron's Eylea and Novartis' Lucentis stand out as . . .
Boston
